MOBISTA Trademark

Trademark Overview

On Monday, October 19, 2020, a trademark application was filed for MOBISTA with the United States Patent and Trademark Office. The USPTO has given the MOBISTA trademark a serial number of 90262583. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 29, 2024. This trademark is owned by Celldex Therapeutics, Inc.. The MOBISTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of human diseases and medical conditions, namely, cancer, infections, infectious diseases, inflammatory disorders, immune system disorders, autoimmune disorders and transplant rejection; Pharmaceutical preparations and substances for use as vaccine adjuvants, growth factors for stem cells in stem cell mobilization, immune system stimulators and immune system modulators; Diagnostic agents, preparations and substances for medical purposes
mobista

General Information

Serial Number90262583
Word MarkMOBISTA
Filing DateMonday, October 19, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of human diseases and medical conditions, namely, cancer, infections, infectious diseases, inflammatory disorders, immune system disorders, autoimmune disorders and transplant rejection; Pharmaceutical preparations and substances for use as vaccine adjuvants, growth factors for stem cells in stem cell mobilization, immune system stimulators and immune system modulators; Diagnostic agents, preparations and substances for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, December 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelldex Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827
Party NameCelldex Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827

Trademark Events

Event DateEvent Description
Thursday, October 22, 2020NEW APPLICATION ENTERED
Friday, March 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, December 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 18, 2021ASSIGNED TO EXAMINER
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 3, 2021SOU EXTENSION 1 FILED
Friday, December 3, 2021SOU TEAS EXTENSION RECEIVED
Friday, December 3, 2021SOU EXTENSION 1 GRANTED
Tuesday, November 29, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 29, 2022SOU EXTENSION 3 FILED
Tuesday, December 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 21, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 21, 2022SOU EXTENSION 2 FILED
Tuesday, June 21, 2022SOU EXTENSION 2 GRANTED
Thursday, June 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 29, 2022SOU EXTENSION 3 GRANTED
Thursday, December 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 25, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 25, 2023SOU EXTENSION 4 FILED
Thursday, May 25, 2023SOU EXTENSION 4 GRANTED
Saturday, May 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 1, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 1, 2023SOU EXTENSION 5 FILED
Monday, December 11, 2023SOU EXTENSION 5 GRANTED
Monday, December 11, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 29, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 29, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, December 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

mobista immune disorders system substances preparations stem diseases pharmaceutical medical factors